Compare NBTX & TCBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBTX | TCBK |
|---|---|---|
| Founded | 2003 | 1975 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2018 | 1995 |
| Metric | NBTX | TCBK |
|---|---|---|
| Price | $37.81 | $54.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $36.00 | ★ $54.60 |
| AVG Volume (30 Days) | 67.4K | ★ 175.1K |
| Earning Date | 03-31-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.87% |
| EPS Growth | N/A | ★ 6.94 |
| EPS | N/A | ★ 1.04 |
| Revenue | N/A | ★ $53,445,000.00 |
| Revenue This Year | $58.17 | $12.03 |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | ★ N/A | $52.85 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $4.79 | $39.84 |
| 52 Week High | $57.14 | $55.00 |
| Indicator | NBTX | TCBK |
|---|---|---|
| Relative Strength Index (RSI) | 51.60 | 63.24 |
| Support Level | $30.15 | $48.81 |
| Resistance Level | $38.29 | N/A |
| Average True Range (ATR) | 2.46 | 1.12 |
| MACD | 0.45 | 0.22 |
| Stochastic Oscillator | 67.69 | 80.14 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.